Table 1 Tumor stage of MCC patients, as assessed by SSTR-PET and CT
From: Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
No. | SSTR-PET | CT | Up-staging by SSTR-PET | Change of the therapeutic management due to SSTR-PET |
|---|---|---|---|---|
1 | IA* | IA* | No | - |
2 | IA* | IA* | No | - |
3 | IA | IA | No | - |
4 | IA* | IA* | No | - |
5 | IA* | IA* | No | - |
6 | IA* | IA* | No | Parotid surgery (Warthin tumor) |
7 | IIIA* | IIIA* | No | - |
8 | IIIB | IIIB | No | - |
9 | IIIB | IIIB | No | - |
10 | IIIB | IIIB | No | - |
11 | IIIB | IIIB* | No | - |
12 | IIIB* | IIIB* | No | - |
13 | IIIB* | IIIB* | No | - |
14 | IV | IV | No | Bisphosphonate Tx (bone mets) |
15 | IIIB | IIC | Yes | Lymph node exstirpation (positive) |
16 | IV | IV | Yes | - |
17 | IV | IV | No | Bisphosphonate Tx (bone mets) |
18 | IV | IV | No | - |
19 | IV | IV | No | - |
20 | IV | IV | Yes | - |
21 | IV | IV | No | - |
22 | IV | IV | Yes | - |
23 | IV | IV | No | Bisphosphonate Tx (bone mets) |
24 | IV | IV | No | - |